Spinal Muscular atrophy Risk Factor

Spinal Muscular Atrophy Microchapters
Home
Patient Info
Overview
Epidemiology and Demographics
Risk Factors
Screening
Other forms
Molecular Biology
Genetics
Types
Diagnosis
Diagnosis
Full Differential Diagnosis
Symptom
Physical Examination
Electrolyte & Biomarker Studies
Electrocardiogram
Chest X Ray
MRI and CT
Echocardiography or Ultrasound
Other Imaging Findings
Pathology
Other Diagnostic Studies
Treatment
Outcome measures
Therapeutics development
Indications For Surgery
Research
Pre-Operative Assessment
Post-Operative Assessment
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Spinal Muscular atrophy Risk Factor Resources
Most recent articles on Spinal Muscular atrophy Risk Factor
Most cited articles on Spinal Muscular atrophy Risk Factor
Review articles on Spinal Muscular atrophy Risk Factor
Review articles on Spinal Muscular atrophy Risk Factor
CME Programs on Spinal Muscular atrophy Risk Factor
Powerpoint slides on Spinal Muscular atrophy Risk Factor
Images of Spinal Muscular atrophy Risk Factor
Ongoing Trials on Spinal Muscular atrophy Risk Factor at Clinical Trials.gov
US National Guidelines Clearinghouse on Spinal Muscular atrophy Risk Factor
NICE Guidance on Spinal Muscular atrophy Risk Factor
FDA on Spinal Muscular atrophy Risk Factor
CDC on Spinal Muscular atrophy Risk Factor
Spinal Muscular atrophy Risk Factor in the news
Blogs on Spinal Muscular atrophy Risk Factor
Directions to Hospitals Treating Spinal Muscular atrophy Risk Factor
Risk calculators and risk factors for Spinal Muscular atrophy Risk Factor

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

• ~98% of parents of an affected child are carriers. Whereas, the rest of 2% that are not carriers have denovo mutation.

• The pattern of inheritance is autosomal recessive in SMA. The risk of occurrence/recurrence if both the parents are carriers is 25%, while the risk of having an unaffected carrier child is 50%.

This means that in every pregnancy there is

• 1 chance in 4 (25% chance) that they will have a child who inherits both copies of the mutated gene. So, there will be no working gene product in the child and he/she will be affected by the condition.
• 1 chance in 4 (25% chance) that their child will inherit both copies of the working gene and will be unaffected by the condition
• 1 chance in 2 (i.e. 2 chances in 4; 50% chance) that their child will inherit the mutated gene and the working copy of the gene from each parent and he/she will be an unaffected carrier of the faulty gene, just like the parents i.e. carrier for the condition